Xiao-Jun Wang, Yun-Xia Huo, Peng-Jun Yang, Jing Gao, Weipeng Hu
{"title":"核糖核苷-二磷酸还原酶亚基 M2 在肺腺癌中的意义","authors":"Xiao-Jun Wang, Yun-Xia Huo, Peng-Jun Yang, Jing Gao, Weipeng Hu","doi":"10.2174/0115665232286359240611051307","DOIUrl":null,"url":null,"abstract":"\n\nThe Ribonucleoside-diphosphate Reductase subunit M2 (RRM2) is\nknown to be overexpressed in various cancers, though its specific functional implications remain\nunclear. This aims to elucidate the role of RRM2 in the progression of Lung Adenocarcinoma (LUAD)\nby exploring its involvement and potential impact.\n\n\n\nRRM2 data were sourced from multiple databases to assess its diagnostic and prognostic\nsignificance in LUAD. We evaluated the association between RRM2 expression and immune\ncell infiltration, analyzed its function, and explored the effects of modulating RRM2 expression\non LUAD cell characteristics through laboratory experiments.\n","PeriodicalId":10798,"journal":{"name":"Current gene therapy","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma\",\"authors\":\"Xiao-Jun Wang, Yun-Xia Huo, Peng-Jun Yang, Jing Gao, Weipeng Hu\",\"doi\":\"10.2174/0115665232286359240611051307\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nThe Ribonucleoside-diphosphate Reductase subunit M2 (RRM2) is\\nknown to be overexpressed in various cancers, though its specific functional implications remain\\nunclear. This aims to elucidate the role of RRM2 in the progression of Lung Adenocarcinoma (LUAD)\\nby exploring its involvement and potential impact.\\n\\n\\n\\nRRM2 data were sourced from multiple databases to assess its diagnostic and prognostic\\nsignificance in LUAD. We evaluated the association between RRM2 expression and immune\\ncell infiltration, analyzed its function, and explored the effects of modulating RRM2 expression\\non LUAD cell characteristics through laboratory experiments.\\n\",\"PeriodicalId\":10798,\"journal\":{\"name\":\"Current gene therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2024-06-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current gene therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/0115665232286359240611051307\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current gene therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115665232286359240611051307","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma
The Ribonucleoside-diphosphate Reductase subunit M2 (RRM2) is
known to be overexpressed in various cancers, though its specific functional implications remain
unclear. This aims to elucidate the role of RRM2 in the progression of Lung Adenocarcinoma (LUAD)
by exploring its involvement and potential impact.
RRM2 data were sourced from multiple databases to assess its diagnostic and prognostic
significance in LUAD. We evaluated the association between RRM2 expression and immune
cell infiltration, analyzed its function, and explored the effects of modulating RRM2 expression
on LUAD cell characteristics through laboratory experiments.
期刊介绍:
Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.
Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.